Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21071270 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Cetuximab + Gemox in Biliary Tract Cancer
Conditions: Unresectable;   Locally Advanced;   Metastatic
Intervention: Drug: Cetuximab + Gemcitabine + Oxaliplatin

Indicates status has not been verified in more than two years